tiprankstipranks
Advertisement
Advertisement
Ionis Pharmaceuticals price target lowered to $90 from $115 at Barclays
PremiumThe FlyIonis Pharmaceuticals price target lowered to $90 from $115 at Barclays
15h ago
Ionis Pharmaceuticals Reaffirms 2026 Financial Guidance Outlook
Premium
Company Announcements
Ionis Pharmaceuticals Reaffirms 2026 Financial Guidance Outlook
15h ago
Eric Joseph Lifts Ionis Price Target to $100, Reaffirming Buy Amid Adjusted Pipeline and Royalty Assumptions
Premium
Ratings
Eric Joseph Lifts Ionis Price Target to $100, Reaffirming Buy Amid Adjusted Pipeline and Royalty Assumptions
16h ago
Midday Fly By: PepsiCo reports mixed Q2, Levi Strauss posts ‘beat and raise’
PremiumThe FlyMidday Fly By: PepsiCo reports mixed Q2, Levi Strauss posts ‘beat and raise’
1d ago
Ionis Pharmaceuticals falls -22.5%
Premium
The Fly
Ionis Pharmaceuticals falls -22.5%
1d ago
Ionis Pharmaceuticals price target lowered to $94 from $108 at TD Cowen
Premium
The Fly
Ionis Pharmaceuticals price target lowered to $94 from $108 at TD Cowen
1d ago
Analyst Maintains Buy on Ionis, Viewing CARDIO-TTRansform Miss as Design-Driven and Highlighting 2026 ESC Data as Key Catalyst
PremiumRatingsAnalyst Maintains Buy on Ionis, Viewing CARDIO-TTRansform Miss as Design-Driven and Highlighting 2026 ESC Data as Key Catalyst
1d ago
Is AstraZeneca (AZN) Stock a Buy on Today’s Dip? Here’s What Analysts Have to Say About That
Premium
Market News
Is AstraZeneca (AZN) Stock a Buy on Today’s Dip? Here’s What Analysts Have to Say About That
1d ago
Ionis Pharmaceuticals (IONS) Stock Slammed by Phase 3 Trial Results
Premium
Market News
Ionis Pharmaceuticals (IONS) Stock Slammed by Phase 3 Trial Results
1d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100